Department of Radiotherapy, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Radiol Oncol. 2020 Sep 29;54(4):470-479. doi: 10.2478/raon-2020-0050.
Background The aim of the study was to quantify planned doses to the heart and specific cardiac substructures in free-breathing adjuvant three-dimensional radiation therapy (3D-CRT) and tangential intensity modulated radiotherapy (t-IMRT) for left-sided node-negative breast cancer, and to assess the differences in planned doses to organs at risk according to patients' individual anatomy, including breast volume. Patients and methods In the study, the whole heart and cardiac substructures were delineated for 60 patients using cardiac atlas. For each patient, 3D-CRT and t-IMRT plans were generated. The prescribed dose was 42.72 Gy in 16 fractions. Patients were divided into groups with small, medium, and large clinical target volume (CTV). Calculated dose distributions were compared amongst the two techniques and the three different groups of CTV. Results Mean absorbed dose to the whole heart (MWHD) (1.9 vs. 2.1 Gy, P < 0.005), left anterior descending coronary artery mean dose (8.2 vs. 8.4 Gy, P < 0.005) and left ventricle (LV) mean dose (3.0 vs. 3.2, P < 0.005) were all significantly lower with 3D-CRT technique compared to t-IMRT. Apical (8.5 vs. 9.0, P < 0.005) and anterior LV walls (5.0 vs. 5.4 Gy, P < 0.005) received the highest mean dose (Dmean). MWHD and LV-Dmean increased with increasing CTV size regardless of the technique. Low MWHD values (< 2.5 Gy) were achieved in 44 (73.3%) and 41 (68.3%) patients for 3D-CRT and t-IMRT techniques, correspondingly. Conclusions Our study confirms a considerable range of the planned doses within the heart for adjuvant 3D-CRT or t-IMRT in node-negative breast cancer. We observed differences in heart dosimetric metrics between the three groups of CTV size, regardless of the radiotherapy planning technique.
背景 本研究旨在量化左侧淋巴结阴性乳腺癌自由呼吸辅助三维放疗(3D-CRT)和切线调强放疗(t-IMRT)中心脏和特定心脏亚结构的计划剂量,并评估根据患者个体解剖结构(包括乳房体积),包括心脏体积,对风险器官的计划剂量的差异。
患者和方法 在这项研究中,使用心脏图谱对 60 名患者进行了整个心脏和心脏亚结构的勾画。为每位患者生成 3D-CRT 和 t-IMRT 计划。规定剂量为 42.72 Gy,分为 16 个分数。患者被分为小、中、大临床靶区(CTV)组。比较了两种技术和三种不同 CTV 组之间的计算剂量分布。
结果 3D-CRT 技术与 t-IMRT 相比,全心脏平均吸收剂量(MWHD)(1.9 对 2.1 Gy,P < 0.005)、左前降支冠状动脉平均剂量(8.2 对 8.4 Gy,P < 0.005)和左心室(LV)平均剂量(3.0 对 3.2,P < 0.005)均显著降低。心尖(8.5 对 9.0,P < 0.005)和前 LV 壁(5.0 对 5.4 Gy,P < 0.005)接受的平均剂量(Dmean)最高。MWHD 和 LV-Dmean 随着 CTV 大小的增加而增加,与技术无关。44 名(73.3%)和 41 名(68.3%)患者 3D-CRT 和 t-IMRT 技术的 MWHD 值(<2.5 Gy)较低。
结论 我们的研究证实,在左侧淋巴结阴性乳腺癌的辅助 3D-CRT 或 t-IMRT 中,心脏的计划剂量范围相当大。我们观察到无论放疗计划技术如何,在 CTV 大小的三组之间,心脏剂量学指标存在差异。